Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Coherent Sine Burst Electroporation (CSE) Ablation System US Investigational Device Exemption (IDE) Study for Patients With Atrial Fibrillation

NCT06784466 is registered in ClinicalTrials.gov with Arga Medtech SA as lead sponsor.

NCT NCT06784466
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06784466 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Coherent Sine Burst Electroporation (CSE) Ablation System US Investigational Device Exemption (IDE) Study for Patients With Atrial Fibrillation
Lead sponsor
Arga Medtech SA
Phase
Not applicable
Overall status
Recruiting
Start date
September 10, 2025
Completion date
August 31, 2027
Enrollment
360 (estimated)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation (af), paroxysmal af, persistant atrial fibrillation